Delivery Order SPE2DB22D3010-SPE2DB25FP3QG
- Not listed
- The Defense Logistics Agency awarded a $10,932.80 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of TALTZ 80 mg/ml autoinjectors. This is a firm fixed price, competitively awarded contract with performance at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 7, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. The contract is valued at $5,806.95 with a firm fixed price structure and an ultimate completion date of August 27, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a $4,980.90 delivery order on July 14, 2025, for TALTZ 80 mg/ml autoinjector medication, with performance completion targeted for July 15, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,228.37 on August 11, 2025, for the supply of TALTZ 80 MG/ML AutoInjector (2-pack). This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 12, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract utilizes no set-aside provisions and represents a routine pharmaceutical procurement through established federal...
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order valued at $5,055.05 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,641.24 on August 20, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed price, non-set-aside contract with a completion date of August 21, 2025, and performance location in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Taltz 80 mg/ml autoinjector medication with a ceiling value of $17,030.96. This firm fixed-price delivery order, which is set to conclude on August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a $10,997 firm fixed price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector, with an ultimate completion date of September 26, 2025. This delivery order, issued on September 25, 2025, represents a non-set-aside competitive award and is classified as a child contract under AmerisourceBergen's larger contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of TALTZ 80 mg/ml auto-injector medication. This non-set-aside, competitively awarded contract carries a ceiling value of $6,641.24 under a firm fixed price arrangement, with an ultimate completion date of August 19, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3QGDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $5,562.85 on September 24, 2025, for TALTZ 80 mg/mL auto-injectors. This firm fixed-price, competitively awarded contract is not set-aside and represents a child order under a larger indefinite delivery contract vehicle. The pharmaceutical product will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with completion expected by September 25, 2025. This delivery order falls under AmerisourceBergen's comprehensive $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a broad range of brand-name and generic medications, vaccines, medical devices, and specialty pharmaceuticals to support Defense Health Agency and other government healthcare systems. The company's proven track record of competitively awarded federal contracts and diverse pharmaceutical portfolio demonstrate its capability to meet complex medical procurement requirements for the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/24/25 |